Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

Triptorelin Acetate Dosage Protocol - Peptide Dosages

Triptorelin Acetate (2 mg) Dosage Protocol A potent GnRH-agonist decapeptide (the drug Decapeptyl / Trelstar) that first stimulates, then shuts down, the entire reproductive hormone axis. Research-use-only reference — not medical advice and not a dosing recomm

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Triptorelin Acetate (2 mg) Dosage Protocol

A potent GnRH-agonist decapeptide (the drug Decapeptyl / Trelstar) that first stimulates, then shuts down, the entire reproductive hormone axis. Research-use-only reference — not medical advice and not a dosing recommendation.

Why Triptorelin draws research interest

These are the directions researchers and the peptide community most often explore Triptorelin for — so you know you’re in the right place. They describe what is being studied, not proven benefits, approved uses, or promised results.

It stimulates first, then suppresses — the flare is the catch

The counterintuitive thing about GnRH agonists like triptorelin is that they begin by doing the opposite of their therapeutic goal. Continuous strong stimulation of the pituitary GnRH receptor initially <em>increases</em> LH and FSH release, driving a transient surge in testosterone (in men) or estrogen (in women) over roughly the first one to two weeks. Only after that does the receptor desensitize and down-regulate, at which point gonadotropins and sex hormones fall to castrate or menopausal levels. In prostate cancer this early “flare” can briefly worsen the disease — bone pain or urinary obstruction — which is exactly why clinicians often add an antiandrogen for the first weeks. That biphasic behavior is central to understanding the drug and is one more reason it is not a casual compound.

The approved product is a depot, not a vial you reconstitute

Nearly all clinical triptorelin is given as sustained-release microsphere depots designed to release the peptide slowly over one, three or six months from a single intramuscular injection. That controlled, long-duration release is the whole point of the formulation — it keeps the GnRH receptor continuously occupied so suppression is maintained. A plain 2 mg research vial of triptorelin acetate is the immediate-release peptide, which behaves completely differently from a depot. Treating a research vial as if it were the approved medicine misunderstands both the pharmacology and the product, and there is no validated self-injection regimen for it.

A powerful, whole-axis endocrine switch

Triptorelin does not nudge one hormone; it takes the entire hypothalamic–pituitary–gonadal axis offline. In men that means medical castration — very low testosterone, hot flushes, loss of libido and erectile function, and, over months, bone-density loss. In women it induces a menopause-like state with the corresponding effects. These are profound, system-wide changes that are useful when a clinician deliberately wants them for a defined condition, and are risky and inappropriate when self-induced. The honest framing is that this is a specialist hormonal therapy, not something to experiment with.

Evidence ranges from early laboratory work to clinical trials depending on the use — the sections below cover the actual data and sources.

Mix & measure Triptorelin · 2 mg

Pre-filled with this protocol’s recommended BAC water and documented starting dose — edit any field to run your own numbers.

Reconstitution math only — not dosing advice. U-100 syringe: 100 units = 1 mL. Full reconstitution guide → · Advanced calculator →

A long-acting GnRH agonist that over-stimulates the pituitary GnRH receptor. The first days bring a surge of LH, FSH and sex hormones (the "flare"); continued exposure then desensitizes and down-regulates the receptor, collapsing LH/FSH and driving testosterone or estrogen down to castrate/menopausal levels.

An approved prescription hormone (Decapeptyl, Trelstar, Diphereline) delivered as long-acting depot microspheres for prostate cancer, endometriosis, uterine fibroids and central precocious puberty. It is used to induce a controlled, reversible medical castration under specialist supervision, not as a wellness or performance peptide.

Clinical trials establish that triptorelin depots reliably suppress testosterone to castrate levels in prostate cancer, with a well-characterized early testosterone flare that can transiently worsen hormone-driven disease unless covered. The mechanism and suppression are well documented; none of that evidence supports self-administering a research vial.

Quickstart Highlights

Triptorelin is a synthetic decapeptide agonist of gonadotropin-releasing hormone (GnRH) — a modified version of the body’s own GnRH that binds the pituitary GnRH receptor far more strongly and for far longer. It is the active ingredient in the approved medicines Decapeptyl, Trelstar and Diphereline, used to switch off sex-hormone production in conditions such as prostate cancer, endometriosis and central precocious puberty[1][2].

This page is an educational reference on what triptorelin is, the unusual two-phase way it works, and what the research shows. It is not medical advice and not a protocol to self-administer the peptide. Two facts matter up front. First, triptorelin does not gently “boost” hormones — it produces an initial surge and then a deep, sustained suppression of the whole reproductive axis[2]. Second, the approved products are long-acting depot injections (monthly, 3-monthly or 6-monthly microspheres), not a simple reconstituted vial — so a 2 mg research vial is not the approved medicine.

A GnRH-agonist decapeptide (the drug Decapeptyl / Trelstar) that binds the pituitary GnRH receptor and, after an initial surge, suppresses LH, FSH and sex-hormone output[2].

Biphasic: a flare (transient rise in testosterone/estrogen) for the first ~1–2 weeks, then down-regulation to castrate-level suppression[1][2].

FDA-approved as depot triptorelin (Trelstar/Decapeptyl). A grey-market 2 mg research vial is not the approved long-acting product and is not quality-assured.

Robust human clinical data for the approved depot in prostate cancer and other indications[4]. That evidence belongs to the depot formulations under medical care, not to self-dosed research vials.

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

Related questions

01Pemvidutide — frequently asked questions

Wipe the stopper with an alcohol swab, then inject your bacteriostatic water slowly down the inside wall of the vial. Let it sit and gently swirl until dissolved — never shake. Store the mixed vial in the refrigerator and draw doses with an insulin syringe. Use the calculator above to turn any dose into syringe units. There is no single correct amount — more water simply spreads the same 5 mg of peptide across a larger volume, which makes small doses easier to measure accurately. 1 to 3 mL per vial is typical. Enter your chosen volume in the calculator above to see the resulting concentration and syringe units. On a U-100 insulin syringe, 100 units equal 1 mL, so 1 unit equals 0.01 mL. The calculator above converts your draw volume into these units automatically so you can measure without doing the math by hand. Keep the reconstituted vial refrigerated at roughly 2 to 8 degrees Celsius, away from light, and avoid freezing it. Reconstituted research peptides are generally used within a few weeks. Always follow the specific guidance supplied with your product. Divide the vial strength of 5 mg by the amount you use per injection. The calculator above reports this as "doses per vial" the moment you enter a dose. No. Pemvidutide is sold strictly for laboratory and research purposes and is not approved by the FDA or other regulators for human use. Everything on this page is research information, not medical advice — consult a licensed healthcare professional before any use.

Source: dosagepeptide.com ↗
02Cortexin — frequently asked questions

Wipe the stopper with an alcohol swab, then inject your bacteriostatic water slowly down the inside wall of the vial. Let it sit and gently swirl until dissolved — never shake. Store the mixed vial in the refrigerator and draw doses with an insulin syringe. Use the calculator above to turn any dose into syringe units. There is no single correct amount — more water simply spreads the same 10 mg of peptide across a larger volume, which makes small doses easier to measure accurately. 1 to 3 mL per vial is typical. Enter your chosen volume in the calculator above to see the resulting concentration and syringe units. On a U-100 insulin syringe, 100 units equal 1 mL, so 1 unit equals 0.01 mL. The calculator above converts your draw volume into these units automatically so you can measure without doing the math by hand. Keep the reconstituted vial refrigerated at roughly 2 to 8 degrees Celsius, away from light, and avoid freezing it. Reconstituted research peptides are generally used within a few weeks. Always follow the specific guidance supplied with your product. Divide the vial strength of 10 mg by the amount you use per injection. The calculator above reports this as "doses per vial" the moment you enter a dose. No. Cortexin is sold strictly for laboratory and research purposes and is not approved by the FDA or other regulators for human use. Everything on this page is research information, not medical advice — consult a licensed healthcare professional before any use.

Source: dosagepeptide.com ↗
03AHK-Cu — frequently asked questions

Wipe the stopper with an alcohol swab, then inject your bacteriostatic water slowly down the inside wall of the vial. Let it sit and gently swirl until dissolved — never shake. Store the mixed vial in the refrigerator and draw doses with an insulin syringe. Use the calculator above to turn any dose into syringe units. There is no single correct amount — more water simply spreads the same 50 mg of peptide across a larger volume, which makes small doses easier to measure accurately. 1 to 3 mL per vial is typical. Enter your chosen volume in the calculator above to see the resulting concentration and syringe units. On a U-100 insulin syringe, 100 units equal 1 mL, so 1 unit equals 0.01 mL. The calculator above converts your draw volume into these units automatically so you can measure without doing the math by hand. Keep the reconstituted vial refrigerated at roughly 2 to 8 degrees Celsius, away from light, and avoid freezing it. Reconstituted research peptides are generally used within a few weeks. Always follow the specific guidance supplied with your product. Divide the vial strength of 50 mg by the amount you use per injection. The calculator above reports this as "doses per vial" the moment you enter a dose. No. AHK-Cu is sold strictly for laboratory and research purposes and is not approved by the FDA or other regulators for human use. Everything on this page is research information, not medical advice — consult a licensed healthcare professional before any use.

Source: dosagepeptide.com ↗
04Amycretin — frequently asked questions

Wipe the stopper with an alcohol swab, then inject your bacteriostatic water slowly down the inside wall of the vial. Let it sit and gently swirl until dissolved — never shake. Store the mixed vial in the refrigerator and draw doses with an insulin syringe. Use the calculator above to turn any dose into syringe units. There is no single correct amount — more water simply spreads the same 5 mg of peptide across a larger volume, which makes small doses easier to measure accurately. 1 to 3 mL per vial is typical. Enter your chosen volume in the calculator above to see the resulting concentration and syringe units. On a U-100 insulin syringe, 100 units equal 1 mL, so 1 unit equals 0.01 mL. The calculator above converts your draw volume into these units automatically so you can measure without doing the math by hand. Keep the reconstituted vial refrigerated at roughly 2 to 8 degrees Celsius, away from light, and avoid freezing it. Reconstituted research peptides are generally used within a few weeks. Always follow the specific guidance supplied with your product. Divide the vial strength of 5 mg by the amount you use per injection. The calculator above reports this as "doses per vial" the moment you enter a dose. No. Amycretin is sold strictly for laboratory and research purposes and is not approved by the FDA or other regulators for human use. Everything on this page is research information, not medical advice — consult a licensed healthcare professional before any use.

Source: dosagepeptide.com ↗
05Thymogen — frequently asked questions

Wipe the stopper with an alcohol swab, then inject your bacteriostatic water slowly down the inside wall of the vial. Let it sit and gently swirl until dissolved — never shake. Store the mixed vial in the refrigerator and draw doses with an insulin syringe. Use the calculator above to turn any dose into syringe units. There is no single correct amount — more water simply spreads the same 10 mg of peptide across a larger volume, which makes small doses easier to measure accurately. 1 to 3 mL per vial is typical. Enter your chosen volume in the calculator above to see the resulting concentration and syringe units. On a U-100 insulin syringe, 100 units equal 1 mL, so 1 unit equals 0.01 mL. The calculator above converts your draw volume into these units automatically so you can measure without doing the math by hand. Keep the reconstituted vial refrigerated at roughly 2 to 8 degrees Celsius, away from light, and avoid freezing it. Reconstituted research peptides are generally used within a few weeks. Always follow the specific guidance supplied with your product. Divide the vial strength of 10 mg by the amount you use per injection. The calculator above reports this as "doses per vial" the moment you enter a dose. No. Thymogen is sold strictly for laboratory and research purposes and is not approved by the FDA or other regulators for human use. Everything on this page is research information, not medical advice — consult a licensed healthcare professional before any use.

Source: dosagepeptide.com ↗
comparison

Pulse versus plateau: the same hormone can build or destroy bone

What makes PTH biology fascinating is that the effect flips depending on how the hormone is delivered. A brief once-daily spike of PTH(1–34) tips the balance toward osteoblasts and net bone…

Source: dosagepeptide.com
Research context

Read sources and limitations before applying a claim.

Why EPO draws research interest

These are the directions researchers and the peptide community most often explore EPO for — so you know you’re in the right place. They describe what is being studied, not proven benefits, approved uses, or promised results.

Source: dosagepeptide.com ↗

Handling and Reconstitution in a Research Context

This section describes how NAD+ and its precursors are handled as laboratory materials, because handling directly affects the reproducibility and interpretability of research. It is not a how-to for self-administration and carries no implication that these compounds should be used to address Parkinson’s disease or any other condition outside a properly authorized study. The clinical trials discussed above used pharmaceutical-grade oral capsules manufactured and quality-controlled to trial standards, which is a very different thing from a lyophilized research vial. Oral precursors such as NR and NMN are the simplest to handle because they are supplied as capsules or powders intended for oral use, and the human Parkinson’s trials all used the oral route.1,2 Their main practical vulnerabilities are moisture and heat: NMN in particular is hygroscopic and can degrade if exposed to humidity, so powders are kept sealed, cool, and dry, and analytical labs verify content by high-performance liquid chromatography rather than trusting label claims. For any quantitative experiment, confirming compound identity and purity before use is a basic control, because degraded or mislabeled material is a common hidden source of irreproducibility. Lyophilized (freeze-dried) NAD+ intended for reconstitution introduces additional handling considerations that mirror those of injectable research peptides. Freeze-dried material is generally stored frozen, often at minus 20 degrees Celsius or colder, with colder storage preferred for long-term stability, and is protected from light and repeated freeze-thaw cycling, each of which can degrade sensitive dinucleotides. Reconstitution is typically performed with a sterile diluent added slowly down the inner wall of the vial rather than directly onto the powder, followed by gentle swirling rather than vigorous shaking, since mechanical agitation and foaming can damage the molecule; the vial is then allowed to dissolve fully before use. Once in solution, NAD+ is far less stable than in its dried state and is kept refrigerated at roughly 2 to 8 degrees Celsius and used within a limited window, on the order of days to a couple of weeks depending on conditions, because aqueous NAD+ hydrolyzes over time. Concentration is a function of the diluent volume added to a known mass; laboratories track this explicitly so that any downstream measurement is traceable to a defined concentration. General principles of this kind are covered in the site’s peptide reconstitution guide and the associated reconstitution calculator, which exist to support accurate laboratory record-keeping rather than to encourage use. Two broader points frame all of this. First, handling quality is a research-validity issue before it is anything else: an experiment run with degraded, contaminated, or inaccurately concentrated material produces uninterpretable data, which is one way that poorly controlled work generates the exaggerated claims this article is trying to counter. Second, none of these handling details change the compounds’ status. A carefully reconstituted NAD+ solution is still an unapproved research material, and meticulous technique does not convert a preclinical hypothesis into a validated Parkinson’s treatment. The site’s general research compound reference index catalogs handling parameters for many such materials on the same understanding: they are educational references for people working in controlled settings, not endorsements of use.

Source: dosagepeptide.com ↗
Practical and safety references

These excerpts are educational, not personalised medical instructions.

How-to reference

How to convert mcg to mg (and back)

Because the factor is exactly 1000, every conversion is a decimal-point move of three places — no calculator strictly required once you see the pattern: mcg → mg: divide by 1000, i.e. move the decimal point three places to the left. 500 mcg → 0.5 mg; 100 mcg → 0.1 mg; 1500 mcg → 1.5 mg. mg → mcg: multiply by 1000, i.e. move the decimal point three places to the right. 0.5 mg → 500 mcg; 2 mg → 2000 mcg; 1.25 mg → 1250 mcg. The tool above does the same move for you and trims trailing zeros, so you can paste in any value — whole or fractional — and read the exact counterpart.

Source: dosagepeptide.com ↗
Dosage reference

Ara-290 (16mg Vial) Dosage Protocol

Cibinetide — investigational non-erythropoietic EPO-derived peptide; in Phase 2, not approved.

Source: dosagepeptide.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →